Cell-based and cytokine-directed chemical screen to identify potential anti-multiple myeloma agents Fulltext Access 8 Pages 2010
Ezrin is a key molecule in the metastasis of MOLT4 cells induced by CCL25/CCR9 Fulltext Access 8 Pages 2010
Maintaining Bone Health in Prostate Cancer Throughout the Disease Continuum Fulltext Access 8 Pages 2010
The Evolving Role of Bone-Conserving Therapy in Patients With Breast Cancer Fulltext Access 8 Pages 2010
CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: Proposal for an accelerated diagnostic flowchart Fulltext Access 8 Pages 2010
Adjuvant Chemotherapy for Resected Stage II and III Colon Cancer: Comparison of Two Widely Used Prognostic Calculators Fulltext Access 8 Pages 2010
Elevated mRNA level of hST6Gal I and hST3Gal V positively correlates with the high risk of pediatric acute leukemia Fulltext Access 8 Pages 2010
ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as “leukemic phase” Fulltext Access 8 Pages 2010
Traditional Statistical Methods for Evaluating Prediction Models Are Uninformative as to Clinical Value: Towards a Decision Analytic Framework Fulltext Access 8 Pages 2010
All-trans retinoic acid inhibits the differentiation, maturation, and function of human monocyte-derived dendritic cells Fulltext Access 8 Pages 2010
Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines Fulltext Access 8 Pages 2010
Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors Fulltext Access 8 Pages 2010
NFκB modulators in a model of glucocorticoid resistant, childhood acute lymphoblastic leukemia Fulltext Access 8 Pages 2010
Combined proteasome and histone deacetylase inhibition: A promising synergy for patients with relapsed/refractory multiple myeloma Fulltext Access 8 Pages 2010
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study Fulltext Access 8 Pages 2010
Reduced proliferation of non-megakaryocytic acute myelogenous leukemia and other leukemia and lymphoma cell lines in response to eltrombopag Fulltext Access 8 Pages 2010
Flow cytometry vs cytomorphology for the detection of hematologic malignancy in body cavity fluids Fulltext Access 8 Pages 2010
A diphtheria toxin interleukin-3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia Fulltext Access 8 Pages 2010
Clinical Studies With Anti-CTLA-4 Antibodies in Non-melanoma Indications Fulltext Access 8 Pages 2010
Identification of suitable endogenous controls and differentially expressed microRNAs in canine fresh-frozen and FFPE lymphoma samples Fulltext Access 8 Pages 2010
The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells Fulltext Access 8 Pages 2010
Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: Results from the Malaysia-Singapore ALL Study Group Fulltext Access 8 Pages 2010
Differential activities of thalidomide and isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells Fulltext Access 8 Pages 2010
Inhibition of MEK/ERK1/2 sensitizes lymphoma cells to sorafenib-induced apoptosis Fulltext Access 8 Pages 2010
Practical Considerations in the Evaluation and Management of Adrenocortical Cancer Fulltext Access 8 Pages 2010
Uses and Limitations of Portal Vein Embolization for Improving Perioperative Outcomes in Hepatocellular Carcinoma Fulltext Access 8 Pages 2010
The aryl hydrocarbon receptor: Regulation of hematopoiesis and involvement in the progression of blood diseases Fulltext Access 8 Pages 2010
Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI) Fulltext Access 8 Pages 2010
Self inhibition of phagocytosis: The affinity of ‘marker of self’ CD47 for SIRPα dictates potency of inhibition but only at low expression levels Fulltext Access 8 Pages 2010
Does vitamin D supplementation of healthy Danish Caucasian girls affect bone turnover and bone mineralization? Fulltext Access 8 Pages 2010
A functional screen for regulatory elements that improve retroviral vector gene expression Fulltext Access 8 Pages 2010
Recruitment of Adolescents and Young Adults to Cancer Clinical Trials—International Comparisons, Barriers, and Implications Fulltext Access 8 Pages 2010
Thrombospondin-2 regulates matrix mineralization in MC3T3-E1 pre-osteoblasts Fulltext Access 8 Pages 2010
COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation Fulltext Access 8 Pages 2010
Characterisation of human bone marrow stromal cell heterogeneity for skeletal regeneration strategies using a two-stage colony assay and computational modelling Fulltext Access 8 Pages 2010
Locoregional Intra-arterial Therapies for Unresectable Intrahepatic Cholangiocarcinoma Fulltext Access 8 Pages 2010
Sex-specific effect of Pirin gene on bone mineral density in a cohort of 4000 Chinese Fulltext Access 8 Pages 2010
mTOR inhibitor RAD001 (Everolimus) enhances the effects of imatinib in chronic myeloid leukemia by raising the nuclear expression of c-ABL protein Fulltext Access 8 Pages 2010
Plumbagin induces ROS-mediated apoptosis in human promyelocytic leukemia cells in vivo Fulltext Access 8 Pages 2010
17-N-Allylamino-17-demethoxygeldanamycin induces a diverse response in human acute myelogenous cells Fulltext Access 8 Pages 2010
Transformation of dendritic cells from plasmacytoid to myeloid in a leukemic plasmacytoid dendritic cell line (PMDC05) Fulltext Access 8 Pages 2010
Hyaluronan induces migration of multidrug-resistant lymphoma cell lines in vitro through Tiam1 activation by a PI3K-dependent mechanism Fulltext Access 8 Pages 2010
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor Fulltext Access 8 Pages 2010
Valproic acid exerts differential effects on CXCR4 expression in leukemic cells Fulltext Access 8 Pages 2010
In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia Fulltext Access 8 Pages 2010
Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients Fulltext Access 8 Pages 2010
GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines Fulltext Access 8 Pages 2010
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition Fulltext Access 8 Pages 2010
Protein kinase A activators and the pan-PPAR agonist tetradecylthioacetic acid elicit synergistic anti-leukaemic effects in AML through CREB Fulltext Access 8 Pages 2010
Collaboration between WNT and BMP signaling promotes hemoangiogenic cell development from human fibroblast-derived iPS cells Fulltext Access 9 Pages 2010
Generation of induced pluripotent stem cells from newborn marmoset skin fibroblasts Fulltext Access 9 Pages 2010
The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies Across Clinical Indications Fulltext Access 9 Pages 2010
Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies Fulltext Access 9 Pages 2010
Transarterial Liver-Directed Therapies of Neuroendocrine Hepatic Metastases Fulltext Access 9 Pages 2010
The Role of Anti-Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit? Fulltext Access 9 Pages 2010
The Molecular Basis of Bisphosphonate Activity: A Preclinical Perspective Fulltext Access 9 Pages 2010
Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia Fulltext Access 9 Pages 2010
Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia Fulltext Access 9 Pages 2010
Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma Fulltext Access 9 Pages 2010
Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction Fulltext Access 9 Pages 2010
Obesity Does Not Preclude Safe and Effective Myeloablative Hematopoietic Cell Transplantation (HCT) for Acute Myelogenous Leukemia (AML) in Adults Fulltext Access 9 Pages 2010
Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation Fulltext Access 9 Pages 2010
Combined Submyeloablative and Myeloablative Dose Intense Melphalan Results in Satisfactory Responses with Acceptable Toxicity in Patients with Multiple Myeloma Fulltext Access 9 Pages 2010
Nonmyeloablative Second Transplants are Associated with Lower Nonrelapse Mortality and Superior Survival Than Myeloablative Second Transplants Fulltext Access 9 Pages 2010
Graft-versus-Host Disease: Role of Inflammation in the Development of Chromosomal Abnormalities of Keratinocytes Fulltext Access 9 Pages 2010
Comparison of Cytogenetic Clonal Evolution Patterns following Allogeneic Hematopoietic Transplantation versus Conventional Treatment in Patients at Relapse of AML Fulltext Access 9 Pages 2010
Improved T and B cell recovery by the transfer of slowly dividing human hematopoietic stem cells Fulltext Access 9 Pages 2010
Lung Function and Long-Term Complications after Allogeneic Hematopoietic Cell Transplant Fulltext Access 9 Pages 2010
Spiritual Absence and 1-Year Mortality after Hematopoietic Stem Cell Transplant Fulltext Access 9 Pages 2010
Favorable Outcomes in Patients Surviving 5 or More Years after Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies Fulltext Access 9 Pages 2010
A Preclinical Model of Double- versus Single-Unit Unrelated Cord Blood Transplantation Fulltext Access 9 Pages 2010
Dose intensity of preparative regimens for acute myeloid leukemia – One-size-fits-all or tailor-made? Fulltext Access 9 Pages 2010
Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches Fulltext Access 9 Pages 2010
5-Aza-2′-deoxycytidine sensitizes busulfan-resistant myeloid leukemia cells by regulating expression of genes involved in cell cycle checkpoint and apoptosis Fulltext Access 9 Pages 2010
Different susceptibilities to 1,25-dihydroxyvitamin D3-induced differentiation of AML cells carrying various mutations Fulltext Access 9 Pages 2010
Histone deacetylase inhibitors: A new perspective for the treatment of leukemia Fulltext Access 9 Pages 2010
Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors Fulltext Access 9 Pages 2010
Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells Fulltext Access 9 Pages 2010
ZAP-70 intron1 DNA methylation status: Determination by pyrosequencing in B chronic lymphocytic leukemia Fulltext Access 9 Pages 2010
Folylpolyglutamate Synthetase Gene Transcription is Regulated by a Multiprotein Complex that Binds the TEL-AML1 Fusion in Acute Lymphoblastic Leukemia Fulltext Access 9 Pages 2010
Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia Fulltext Access 9 Pages 2010
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: Results from the Hellenic Dendritic Cell Leukemia Study Group Fulltext Access 9 Pages 2010
Proteasome inhibitor-induced apoptosis in acute myeloid leukemia: A correlation with the proteasome status Fulltext Access 9 Pages 2010
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38− compartment Fulltext Access 9 Pages 2010
Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation Fulltext Access 9 Pages 2010
Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies Fulltext Access 9 Pages 2010
A myeloma translocation-like model associating CCND1 with the immunoglobulin heavy-chain locus 3′ enhancers does not promote by itself B-cell malignancies Fulltext Access 9 Pages 2010